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Abstract 
 
Objective 
Practice guidelines are an important support tool for health behaviour change. 
However, the effective implementation of guidelines can be difficult and the gaps that 
exist between guidelines and practice may be intractable. In this paper we examine a 
neglected, but important, area: understanding the reasons why problems may develop 
in the implementation and uptake of practice guidelines. To do so we explore the 
existence of gaps in the translation of evidence into practice based guidelines for 
health promotion. 
 
Approach 
Drawing on relevant literature we examine the case of influenza vaccination, in 
particular, guidelines that advise influenza vaccination for all health care workers. We 
highlight gaps between the actions advised within these guidelines and the relevant 
evidence and explore some of the processes that have amplified and obscured this 
evidence during the development of guidelines. 
 
Implications 
The current processes that underlie the translation of evidence into practice guidelines 
risk the loss of the nuanced and rich information that is needed for individual 
decision-making. Where evidence is limited, the propagation of evidence-guidelines 
gaps, without transparency as to the basis of decision-making, compromises the 
credibility of guidelines and places at risk the many benefits that guidelines can 
provide.  
 
Conclusion 
We argue that evidence-guideline gaps may arise because of a range of problems with 
the nature of the evidence used to justify the guidelines and the way in which that 
evidence is applied and interpreted. We suggest that these problems may bring 
potentially useful guidelines into disrepute. 
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Introduction 
 
Evidence-based practice guidelines are an important support tool for clinical practice, 
clinical decision-making and funding decisions at the policy level.  Practice guidelines 
have the potential to offer improved efficiency and value for money with regard to 
service delivery, consistency in care and reduced morbidity and mortality.1 Practice 
guidelines also support quality decision-making by health care workers (HCWs) and 
policy makers in an environment where research is constantly evolving. However, 
effective implementation of guidelines may be difficult, and many gaps between 
guidelines and practice remain resistant to intervention.2-4 Considerable resources are 
invested in education, support measures, inducements and enforcement in order to 
encourage adherence to guidelines and reduce guidelines-practice gaps. 2-4 
In contrast, the gaps that exist between evidence and guidelines have been relatively 
neglected. We contend that such gaps do exist and that they have the potential to 
compromise the effectiveness of efforts in preventative health.  
 
Objective 
In this paper, we explore the implications of gaps between evidence and guidelines 
through examination of a case study. The case study considers the gap between 
guidelines recommending influenza vaccination for all HCWs and the low uptake by 
HCWs in Australia and internationally. Focussing on this case study is useful in 
satisfying the objectives of this paper which are to highlight some of the less well 
recognised, and less frequently discussed, issues that  underpin gaps in the translation 
of evidence into practice and to discuss the consequences thereof.  
 
What’s the problem? 
Despite the emphasis placed on the importance of high quality evidence to underpin 
policy and practice, the evidence used to support guidelines may be of inadequate 
quality or may be misused to underpin particular advocacy positions. We discuss here 
some of the ways in which the use or misuse of evidence in the development of 
guidelines can be problematic (summary provided in Table 1).  
Paucity of evidence 
Questions about the nature of evidence and the relative value of different types of 
evidence are heavily debated in academia and the policy arena. Evidence based 
medicine arose from a scientific tradition which privileges the notion of ‘facts’ 
existing independent of the observer. Scientific methods reinforce this apparent 
separation through techniques such as randomisation and statistical analysis of 
outcome measures. Such approaches are invaluable in providing particular types of 
evidence to inform decision making but they are limited by the very characteristics 
which make them desirable, particularly for questions which must be researched in 
‘real world’ conditions. In particular, evidence collection through randomised 
controlled trials may be unsuitable for public health interventions. Public health 
evidence is frequently collected through different frames of evidence such as cross-
sectional studies or natural experiments (e.g. John Snow’s pump handle or Richard 
Doll’s work on cancer and smoking). Brownson et al suggest that strict adherence to a 
“hierarchy of study designs may reinforce an inverse evidence law by which 
interventions most likely to influence whole populations (e.g. policy change) are least 
valued”.5, p.179 In addition, none of the methods normally considered within the rubric 
of evidence production may be useful for translating evidence into practice.  
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Evidence extension 
Muir Gray notes that the “absence of excellent evidence does not make evidence-
based decision making impossible; what is required is the best evidence available not 
the best evidence possible”.6, p.61 However, in choosing public health interventions, 
the only evidence available may be studies carried out in controlled conditions with 
little relationship to real world circumstances.7 There is also a temptation, in the 
absence of good evidence, to support ‘culturally’ shared beliefs and to extend 
evidence collected in related but different circumstances to support the intervention of 
choice. In extending the evidence, with application to the specific case, to a more 
general application, the applicability of the evidence may be uncertain. Extension of 
evidence might be considered to fall under the rubric of ‘expert opinion’. This might 
be acceptable if the uncertainties were recognised and acknowledged. However, as we 
discuss in our case study, they may be masked by citation bias and amplification to 
the point where they become the shared cultural belief of the specific expert 
community or ‘factoids’, assertions that are reported so often that they are considered 
to be true.8, 9 
Citation bias and amplification 
Citation practices may operate to obscure uncertainty that exists within research 
evidence. Steven Greenberg explores this issue,10 particularly the way in which 
scientific claims become validated through citation patterns. For Greenberg, citation 
provides a public record of the belief system that is shared within a community. 
Therefore, analysis of citation patterns in relation to particular claims, provide insight 
into, not only what is written, but also how it is supported. Greenberg’s findings 
reveal how citation can be used as a tool of persuasion for particular claims. 
Greenberg suggests that the certainty of claims within medical research is constructed 
through citation in several ways, two of which he refers to as citation bias and 
amplification. He defines citation bias as ways that authors exclude primary data that 
weakens or contests the claims that they aim to represent as valid. In contrast, 
amplification occurs when a small number of papers, regardless of whether these are 
influential or peripheral, are cited repeatedly in support of particular claims without 
the concurrent presentation of new data. Both result in systematic support of 
particular claims and the loss of potentially valuable, but alternative, understandings. 
Dead-end citation 
Dead-end citation is the use of citations as “tools of persuasion” to support a line of 
reasoning even though the citations do not contain relevant evidence.10  It is not clear 
why authors would choose to cite papers which provide a dead-end for a reader. 
Gilbert suggests this may be to “provide justifications for the positions adopted in a 
paper”. or to demonstrate “allegiance to a particular section of the scientific 
community”.11 Alternatively it may reflect careless citation practice or entrenched 
community beliefs and we will examine the latter in our case study.  
Over- simplification 
Risk communication is complex and difficult but perhaps no more so than in public 
health where the risk may be anticipated or distant rather than existing and immediate. 
There is, therefore, a temptation to simplify messages with the objective of improving 
understanding. There is a great deal of merit in providing clear and simple 
instructions. However, as our case study demonstrates, over-simplification may 
impede transmission of the type and amount of information needed to make sense of a 
complex situation. This may have the perverse effect of preventing or discouraging 
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people from engaging in active management of their own health. In particular, a focus 
on text constructs, such as word and sentence length, may result in a loss of content 
richness such that the message is more easily read but less comprehensible.  
Zarcadoolas describes this as “communication by subtraction”.12 Oversimplification 
of public health messages may be seen by an increasingly health literate public and a 
highly health literate health workforce as patronising. Leask argues that a convinced 
and convincing GP may be the cornerstone of a successful vaccination campaign.13 
Yet a policy position stated with certainty, which is then shaken by adverse events, 
may cause loss of confidence in the expert authority, greater than would have 
occurred had the uncertainty in the evidence been acknowledged and communicated. 
This factor may have contributed to the 2010/11 public response to the withdrawal of 
FluVax vaccination for children in Australia.14 
 
We believe that it would be simplistic to suggest that public health policy and practice 
is based on evidence alone or that other factors are not involved in decision-making.15 
However, presenting guidelines as ‘evidence based’ opens them to critique 
particularly when proposals for public health policies involving compulsory measures 
are drawn from this evidence base. 
 
Approach 
In order to explore and demonstrate the issues described above we use a case study. In 
our work we have encountered several cases where it is apparent that one or more of 
the factors described in Table 1 can be identified in guideline development. However, 
the case study we have chosen is relatively unique in incorporating all of these 
factors. Our case study is based on a review of national guidelines for seasonal 
influenza vaccination for HCWs in five countries: Australia, NZ, USA, Canada and 
the UK. (Table 2) We examined the recommendations of these documents and the 
evidence which was described as underpinning them. The objective here was not to 
provide an analysis of these documents but rather to draw from them examples of the 
factors described in Table 1 to explicate our argument. In particular, we focussed on 
the evidence base presented and whether these reflect the primary source. Our work is 
informed by a systematic review of evidence for the efficacy, effectiveness and safety 
of influenza vaccines carried out for a previous study.16 This review was updated with 
searches within the Scopus database for the years January 2000-November 2011 using 
the keyword combination of:  ((health care worker* OR healthcare worker* OR health 
care personnel OR healthcare personnel), AND influenza AND vaccin* AND NOT 
pandemic).  
Examination of the guidelines for health care worker vaccination  
 
There are clear guidelines, both in Australia and the other four countries reviewed, for 
HCWs to vaccinate against influenza. (Table 2) Vaccination for influenza is 
considered to be an efficacious public health intervention which reduces the burden of 
influenza illness and it can also be framed as an issue of occupational health and 
safety and respect for patient safety. Vaccination programs have been one of the 
greatest success stories of public health. One consequence of this is that there are 
strongly held beliefs amongst individuals working in infectious disease and many 
working in public health, that vaccination is beneficial and advantageous under any 
circumstances. There are recorded instances of transmission of influenza from HCWs 
to patients.17, 18 and it is reasonable to believe that transmission rates are higher than 
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documented.  However, there is also considerable resistance to influenza vaccine 
uptake: without significant efforts to encourage vaccination, staff vaccination rates are 
low. 19, 20 Even with significant encouragement and support, in the absence of 
mandatory requirements, staff uptake is usually well below the universal coverage 
required to best protect patients.19, 20 In this paper we examine the gaps between 
evidence, guidelines and practice for HCW influenza vaccination rates.  
 
We begin with the evidence. Seasonal influenza vaccines are around 80% effective in 
healthy adults, with the effectiveness being even higher when there is a close match 
between the vaccine and the circulating viral strain.21 There is also some evidence that 
the HCW vaccination for influenza decreases staff illness and absenteeism22-24 and is 
cost-effective with respect to both direct costs of health care acquired infection and 
indirect costs of staff absenteeism.25-28 
 
Direct evidence that HCW vaccination reduces transmission of influenza virus in 
health care settings and reduces patient mortality is more difficult to find. Individual 
studies and a Cochrane review of influenza vaccination for aged-care workers (which 
draws on two RCTs and one cohort study) suggest there is some evidence that this 
intervention is effective in protecting the elderly in care settings.29 A later Cochrane 
review, which pooled data from three cluster RCTs30-32, found no effect on influenza, 
pneumonia and death from pneumonia, although there was lower resident all-cause 
mortality and reduced influenza-like illness.33 The Cochrane review33 highlights this 
inconsistency and the authors suggest that it is the result of biased selection of 
subjects, and/or performance bias in that the studies were underpowered to detect the 
outcomes of interest because of low levels of vaccine uptake in the intervention arms of the 
studies. Either way, currently, there is a paucity of evidence to support substantial 
investment in HCW vaccination programs in order to protect patients from 
nosocomial influenza infection in hospital settings.  
 
Beyond this, we suggest that it is problematic to extend evidence found in aged care 
setting to hospitals where visitors are more common and staff numbers larger and 
turning over more frequently. A single longitudinal observational hospital study found 
significant declines in nosocomial influenza infection amongst patients and staff when 
HCW influenza vaccination increased from 4% to 67%34 but the level of evidence is 
low. None of the studies described above provide high quality evidence that 
vaccinating HCWs would result in statistically significant reductions in nosocomial 
seasonal influenza infection in hospital or clinic settings. Given the economic 
investment in influenza vaccination programs for HCWs, the absence of high quality 
evidence is striking.  
 
However it can also be argued that such evidence is very difficult to collect.35 RCTs 
would be impossible to conduct since these would require random selection of 
hospitals to mandatory HCW influenza vaccination or non-vaccination arms. Such an 
approach would be unethical for a number of reasons including infringement of 
personal autonomy and possible harms to HCWs from vaccination or non-
vaccination. Such RCTs would also be extremely difficult to execute and 
prohibitively expensive. However, a natural experiment is currently underway with 
mandatory vaccination for influenza recently instituted at some US health 
institutions36 and it could be feasible to compare these institutions with matched 
control institutions.  
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Despite the lack of evidence, guidelines in the countries examined are often 
underpinned by claims that such evidence exists. For example, the Australian 
Immunisation Handbook 9th Edition, in recommending the vaccination of HCWs, 
states “it has been shown that vaccinating [HCWs] protects those at high-risk”37, p.192 
and cites a single paper which relates to the use of vaccination of aged-care workers 
to protect the elderly in their care.32 This paper and similar papers30, 31, 38, describing 
work in aged care settings, are cited repeatedly in support of guidelines for universal 
HCW vaccination, an example of citation bias (see Table 1). Selective reporting of 
findings may also introduce bias. For example, the 2010 Recommendations of the 
Advisory Committee on Immunization Practices (ACIP) which form the basis of the 
USA’s CDC recommendations states that “A review concluded that vaccination of 
HCP in settings in which patients also were vaccinated provided significant 
reductions in deaths among elderly patients from all causes and deaths from 
pneumonia.”39, p.26 What ACIP recommendations do not state is the other finding of 
the cited review: “If patients were not vaccinated, staff immunisation had no effect”40, 
p.273 The authors of the ACIP recommendations have selectively used the finding from 
the review which supports their recommendations for HCW vaccination while failing 
to include the finding from the same review which does not support their case. In a 
similar example, the Canadian Statement on Seasonal Trivalent Inactivated Influenza 
Vaccine (TIV) for 2010-2011,41 reports both the findings of the papers described 
above and the 2010 Cochrane review33, while glossing over the review’s findings as 
to the need for patient vaccination and potential bias in the included studies. It is 
highly probable that, in health care settings, most patients are neither vaccinated nor 
located in cloistered environs characteristic of aged care facilities. Therefore, it could 
be argued that there is, at present, no direct evidence to support universal HCW 
influenza vaccination.  
 
Citation amplification is apparent in the numerous peer reviewed publications which 
advocate mandates for universal HCW influenza vaccination and in the immunisation 
recommendations listed in Table 2. For example, a Scopus database search for papers 
advocating compulsory universal HCW influenza vaccination published during 
2010,which included reference to supportive evidence, identified 16 papers, all of 
which relied on one or more of four papers describing work in aged or long-term care 
settings30-32, 38 or a single longitudinal observational study .34 The literature 
advocating universal HCW influenza vaccination resembles an inverted pyramid – a 
large volume of review and commentary articles supported by a very small number of 
empirical studies carried out in long-term care settings. In addition, the guidelines 
listed in Table 1 are often used to lend legitimacy to the arguments for universal and 
compulsory influenza HCW vaccination 
 
Dead-end citation is evident in a discussion paper from the Australian influenza 
specialist group, an influential group with respect to Australian vaccination policy, 
which recommends that HCWs vaccinate against influenza thereby “indirectly 
protecting those most vulnerable to the virus”.42 To support this recommendation the 
authors cite studies examining: HCW attitudes to vaccination43, ethical issues 
associated with HCW vaccination44, 45 and risk of acquisition of influenza in non-
vaccinated HCWs .46, 47 None of these studies could be considered to provide direct 
evidence for the value of HCW influenza vaccination in the protection of patients. 
However, if the value of vaccination as a public health tool is considered beyond 
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question, reflecting a culturally shared belief, then the cited papers could be seen to 
provide background arguments for why HCWs should be targeted as a special case 
and for special measures.  
 
Finally, health messages may be oversimplified. In a culture where vaccination is seen 
as universally ‘good’ and non-compliance as irrational nuanced messages about risks 
posed by disease and discussions about uncertainty in evidence, may be seen as 
unnecessary and potentially confusing. Oversimplification may also result in 
downplaying of the potential for adverse post-vaccination events.  The Australian 
Influenza Specialist group position document42 plays down adverse events describing 
them as “negative attitudes and misconceptions”. In doing so, it does not acknowledge 
the burden of the occasional risks with seasonal influenza vaccines described later in 
the document of up to 10% of vaccinated individuals experiencing “symptoms 
mimicking a light influenza infection, such as fever” for up to 48 hours post 
vaccination.42 A figure of 10% is high but may be seen with certain influenza 
vaccines although systemic reactions with placebo injections may also be as high.46 
Recent RCTs in healthy adults over the 2005-06 and 2006-07 showed that fever 
occurred post-vaccination in 3% of participants given active vaccines and 1% of 
participants in the placebo control arm, that is, there is evidence of a mild but real 
reaction in approximately 2% of vaccinated participants in what were mild influenza 
seasons.48 A Canadian qualitative research study49, showed that unvaccinated HCWs 
valued the protective effects of vaccination but did not believe vaccines were 
effective. They also believed that the vaccine made them sick and/or that the focus of 
vaccination was to protect patients to the potential detriment of the HCWs.49 
 
Implications for evidence-practice gaps  
(i) In the case study 
 
In summary, we contend that there are two principal factors characterising the 
evidence-guidelines-practice gap in HCW influenza vaccination: (i) obfuscation of 
uncertainty, in the evidence base and intervention efficacy (ii) oversimplification of 
the vaccination message. These factors reduce transparency and may increase mistrust 
between HCWs, institutional administrators and policy implementers. This has 
ramifications for other areas where staff goodwill and compliance are required. This 
may be particularly so if adverse events occur with other vaccines, such as the 
paediatric FluVax vaccine withdrawn from the Australian market in 2010.   
 
In some sectors, the risk to patients of this guidelines-practice gap may be low and the 
principal adverse outcome may be increased staff absenteeism. However, in sectors 
such as aged care, intensive care and oncology, gaps in vaccine coverage of HCWs 
may place patients at considerable risk and compulsory vaccination of HCWs can be 
readily justified.50 The provision of more complex and nuanced health information for 
HCWs may be beneficial, not only in terms of greater transparency but also in 
building trust between HCWs and administrators and policy makers. Balanced 
discussion of the uncertainty in the evidence and better recognition of the need for 
reciprocal responsibility of institutions towards HCWs, who place themselves at risk 
of adverse vaccination events, may increase both the level of trust and vaccine uptake.  
However, given the poor evidence base and the uncertainty about the degree of risk to 
patients from unvaccinated HCWs in many settings, it may be difficult to justify the 
degree of emphasis currently placed on mandating universal HCW vaccination. There 
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may be well-founded ethical reasons why we might expect HCWs to vaccinate.44, 50 
However, we suggest that, as a society, we should take particular care in making 
demands for strong actions and impositions on individual autonomy where the 
evidence base is poor. 
 
Even with transparently drafted guidelines many HCWs may choose not to vaccinate. 
This may be difficult for many working in infectious disease control to accept. There 
are three courses of action which might be taken. First, greater efforts should be 
undertaken to collect more definitive evidence that universal HCW vaccination would 
make a difference to patient well-being. Modelling may provide some additional 
information.51 Second, should it be decided that universal HCW vaccination can be 
justified on grounds other than evidence, then, in consultation with HCWs, systems 
should be adopted which acknowledge and compensate HCWs for harms experienced. 
Finally, it may be more useful to reinforce HCW vaccination programs where the 
evidence is stronger and target individuals working in high risk, relatively cloistered 
clinical areas. Compulsory vaccination programs in these areas could be allied with a 
strong emphasis on enhanced hygiene practice and staff support. 
 
(ii) For guidelines generally 
 
There is a growing body of literature documenting and critiquing the influence of 
shared scientific or practitioner community belief, in concert with professional power 
and corporate interests, in shaping health policy and clinical practice. In 2009, 
questions were raised about conflicts of interest amongst scientists advising the WHO 
on pandemic planning52, 53 in particular, why these advisors had “declarable financial 
and research ties with pharmaceutical companies producing antivirals and influenza 
vaccines”.53, p1274 Additionally, there was criticism of the lack of communication 
about uncertainty both in the time projections and the evidence for benefits and harms 
associated with pandemic vaccines.53 Similarly, papers54,55 examining the efficacy of 
antiviral drugs detailed concerns about drug company influence and called for 
independent data review. These cases, and similar concerns raised about the nature of 
evidence presentation in the climate change debate,52 provide key lessons for 
guideline producers. Firstly, transparency of process is essential: the public and, in 
this case, HCWs, must be convinced that the guidelines are unbiased and evidence-
based.  Secondly, it is essential to acknowledge uncertainty and document the strength 
of evidence underpinning the guidelines. Evidence from deliberative democratic 
processes and risk communication theory and practice suggests that acknowledging 
uncertainty, in a context of respect for persons, can reduce the divisions between 
experts and lay publics, improve dialogue and increase policy legitimacy.54 
Disseminating half-truths and exaggerated claims are likely to increase mistrust, 
which spills into other areas of vaccine health promotion but, as Sandman and Lanard 
indicate, we do not have much evidence to support that claim.56   Nevertheless, in 
Australia, there are clear guidelines on how to develop guidelines.57 These require that 
the transition from evidence to guidelines be transparent and documented. It is no 
longer sufficient to simply provide a recommendation: the strength of the 
recommendation must be indicated and there are processes for documenting this.58-60 
Adhering to these processes would prevent many of the issues discussed in this paper.  
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Conclusion 
We have shown that evidence-practice gaps may arise, in part, because of problems 
with the nature and application of the evidence used to justify the guidelines.  Many 
of the issues discussed in this case study are apparent in association with other clinical 
and public health guidelines. Although erasing the uncertainty in the evidence base, 
during the translation of evidence into clinical guidelines, may reinforce the presumed 
authority and accuracy of health guidelines, it may also lay the guidelines open to 
disrepute. Building guidelines on evidence which is inadequate, drawn from specific 
contexts which cannot be generalised to the larger group, and which rely on biased 
and poor citation practice, risks more than just guideline non-compliance or the 
perception that specific guidelines may be unwarranted. It risks the credibility of 
guidelines in general. Bringing guidelines into disrepute through the mechanisms 
described in this paper puts at risk the many benefits that they afford. Our plea is for 
greater transparency and honesty in the communication of the uncertainty in the 
evidence underpinning guidelines.  
 
 
 
 
Table 1: Influential factors contributing to evidence-guidelines gaps  
 
 
1. Paucity of evidence: a lack of evidence to support a claim often 
because the evidence is difficult to collect.  
2. Evidence extension: over-extension or amplification of existing 
evidence collected for specific cases but applied on a broader level 
where its applicability is questionable. 
3. Citation bias: amplification of evidence by selective citation in which 
relevant (but conflicting) research is ignored in an attempt to support 
particular views. 
4. Citation amplification: evidence bias by selective citation practice 
where studies, regardless of whether these are influential or peripheral 
papers, are cited repeatedly in support of a particular view. 
5. Dead-end citation: citation(s) to research papers which do not 
contain evidence in support of a claim 
6. Oversimplification: over-simplification of evidence during translation 
into health education messages.  
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Table 2: List of immunisation guidelines and supportive documents  
 
  
Country Auspiced by Document Nature of document 
Australia Department of Health and Ageing; 
NHMRC 
Australian Immunisation Handbook 9th Edition 2008, Section 
3.9 Influenza. 
Advisory with evidence 
 Influenza Specialist Group Influenza Vaccination among Health Care Workers 2009 Discussion paper 
U.K.  Department of Health Green Book Advisory 
 Joint committee on Vaccination and 
Immunisation 
 
Advice on H1N1 and 2010/11 seasonal influenza vaccination 
programmes, 23 July 2010  
 
JCVI statement on seasonal influenza vaccination,30 
December 2010 
Advisory 
 Department of Health 
Protect your patients, your family, yourself: more information 
for health professionals about seasonal influenza vaccination, 
2010 
Leaflet directed at HCWs, 
includes evidence 
U.S.A. Center for Disease Control and 
Prevention 
Morbidity and Mortality Weekly Report (MMWR). Prevention 
and Control of Influenza with Vaccines: Recommendations of 
the Advisory Committee on Immunization Practices (ACIP), 
2010, August 6, 2010 / Vol. 59 / No. RR-8 
 
Advisory with evidence 
New Zealand Ministry of Health Immunisation Handbook May 2011 Section 15 Influenza Advisory 
 National Influenza Strategy group Influenza Medical Website Advise and logistical support 
Canada Public Health Agency of Canada Canada Communicable Disease Report. Vol. 36, 6th August 
2010. Statement on Seasonal Trivalent Inactivated Influenza 
Vaccine (TIV) for 2010-2011 
Advisory with evidence 
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